UroGen Pharma Ltd.

NASDAQ: URGN · Real-Time Price · USD
19.74
-0.34 (-1.69%)
At close: Aug 15, 2025, 3:59 PM
19.50
-1.22%
After-hours: Aug 15, 2025, 06:59 PM EDT

UroGen Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
171.99M 95M 55.41M 44.36M
Short-Term Investments
64.7M 41.97M 44.56M 44.78M
Long-Term Investments
5.02M 4.5M 223K 675K
Other Long-Term Assets
765K 2.26M 2.74M 1.53M
Receivables
20.3M 15.44M 12.7M 11.72M
Inventory
9.23M 5.67M 4.33M 4.83M
Other Current Assets
9.92M 11.1M 11.91M 1.23M
Total Current Assets
276.13M 169.19M 128.91M 114.39M
Property-Plant & Equipment
3.79M 2.36M 3.75M 3.15M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
9.58M 9.13M 6.71M 5.36M
Total Assets
285.71M 178.31M 136.24M 119.75M
Account Payables
10.93M 6.51M 5.53M 5.79M
Deferred Revenue
5.15M n/a 618K n/a
Short-Term Debt
1.53M 819K 941K 3.33M
Other Current Liabilities
-263K 3.04M 1.72M n/a
Total Current Liabilities
45.95M 31.21M 23.92M 22.38M
Long-Term Debt
121.73M 98.55M 97.54M n/a
Other Long-Term Liabilities
125.18M 112.92M 101.94M 88.56M
Total Long-Term Liabilities
248.56M 212.31M 201.06M 88.95M
Total Liabilities
294.51M 243.52M 224.98M 111.33M
Total Debt
123.39M 100.21M 100.06M 398K
Common Stock
115K 89K 63K 61K
Retained Earnings
-806.22M -679.35M -577.1M -467.32M
Comprehensive Income
56K 12K -107K -25K
Shareholders Equity
-8.8M -65.21M -89.36M 8.41M
Total Investments
69.72M 46.47M 44.56M 45.45M